Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism

Both pulsatile gonadotropin-releasing hormone (GnRH) infusion and combined gonadotropin therapy (human chorionic gonadotropin and human menopausal gonadotropin [HCG/HMG]) are effective to induce spermatogenesis in male patients with congenital hypogonadotropic hypogonadism (CHH). However, evidence i...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Jiang-Feng, Liu, Zhao-Xiang, Nie, Min, Wang, Xi, Xu, Hong-Li, Huang, Bing-Kun, Zheng, Jun-Jie, Min, Le, Kaiser, Ursula Brigitte, Wu, Xue-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676428/
https://www.ncbi.nlm.nih.gov/pubmed/28051040
http://dx.doi.org/10.4103/1008-682X.193568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676428/
https://www.ncbi.nlm.nih.gov/pubmed/28051040
http://dx.doi.org/10.4103/1008-682X.193568

Ejemplares similares